Generation of protective immunity against an immunogenic carcinoma requires CD40/CD40L and B7/CD28 interactions but not CD4+ T cells

Cancer Immunology Immunotherapy

Volumn 48, Issue 6, 1999, Pages 336-341

  Eck, Steven C ^a   Turka, Laurence A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

B7 CD28; CD40 CD40L; Lymphocyte depletion; Tumor immunity

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD40 ANTIGEN;

ARTICLE; CARCINOGENICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; HELPER CELL; HUMORAL IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUMOR IMMUNITY; TUMOR REJECTION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; COLONIC NEOPLASMS; FEMALE; GRAFT REJECTION; HEMAGGLUTININS, VIRAL; IMMUNIZATION; IMMUNOCONJUGATES; LYMPHOCYTE DEPLETION; MAMMARY NEOPLASMS, EXPERIMENTAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICE, SCID; NEOPLASM TRANSPLANTATION; RECOMBINANT FUSION PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032848439     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050583     Document Type: Article

References (24)

1. Andersson S, Davis DL, Dahlback H, Jornvall H, Russell DW (1989) Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J Biol Chem 264:8222
2. Aruga E, Aruga A, Arca MJ, Lee WM, Yang NS, Smith JW 2nd, Chang AE (1997) Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF. Cancer Gene Ther 4:157
3. + T cell help. J Exp Med 186:65
4. Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR (1998) Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393:478
5. + T cell response depending on the route of immunization. J Immunol 160:5522
6. Buller RM, Holmes KL, Hugin A, Frederickson TN, Morse HCd (1987) Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature 328:77
7. Chen L, Ashe S, Brady WA, Hellstrom I, Hellstrom KE, Ledbetter JA, McGowan P, Linsley PS (1992) Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71:1093
8. Corbett TH, Griswold DP Jr, Roberts BJ, Peckham JC, Schabel FM Jr (1975) Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res 35:2434
9. Grewal IS, Flavell RA (1998) CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 16:111
10. Guerder S, Matzinger P (1992) A fail-safe mechanism for maintaining self-tolerance. J Exp Med 176:553
11. Kundig TM, Bachmann MF, Lefrancois L, Puddington L, Hengartner H, Zinkernagel RM (1993) Nonimmunogenic tumor cells may efficiently restimulate tumor antigen-specific cytotoxic T cells. J Immunol 150:4450
12. Mackey MF, Gunn JR, Ting PP, Kikutani H, Dranoff G, Noelle RJ, Barth RJ Jr (1997) Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154. Cancer Res 57:2569
13. Mackey MF, Barth RJ Jr, Noelle RJ (1998) The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J Leukoc Biol 63:418
14. Mackey MF, Gunn JR, Maliszewsky C, Kikutani H, Noelle RJ, Barth RJ Jr (1998) Dendritic cells require maturation via CD40 to generate protective antitumor immunity. J Immunol 161:2094
15. Miller AD, Rosman GJ (1989) Improved retroviral vectors for gene transfer and expression. Biotechniques 7:980
16. Morgenstern JP, Land H (1990) Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 18:3587
17. Ostrand-Rosenberg S (1994) Tumor immunotherapy: the tumor cell as an antigen-presenting cell. Curr Opin Immunol 6:722
18. Perdrizet GA, Ross SR, Stauss HJ, Singh S, Koeppen H, Schreiber H (1990) Animals bearing malignant grafts reject normal grafts that express through gene transfer the same antigen. J Exp Med 171:1205
19. + T-helper and a T-killer cell. Nature 393:474
20. + T cells. J Immunol 151:2497
21. Schoenberger SP, Toes RE, Voort EI van der, Offringa R, Melief CJ (1998) T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480
22. Shu S, Plautz GE, Krauss JC, Chang AE (1997) Tumor immunology. JAMA 278:1972
23. Staudt LM, Gerhard W (1983) Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice. J Exp Med 157:687
24. + T cells by B7-transfected melanoma cells. Science 259:368